Mice were habituated to the testing room at least 40 min before behavior test
GLP-1RA ameliorates HFD/PA-induced PPAR downregulation in Islets and NIT-1 cells To elucidate the mechanisms underlying the improvement in glucose homeostasis and pancreatic islet function by GLP-1RA, we conducted RNA-Seq analysis of the pancreatic islets of mice in the NC + saline, HFD + saline, and HFD + Exe groups
Metabolic parameters including glucose tolerance, insulin sensitivity, and IGF-1 levels were monitored throughout the treatment period, confirming that the favorable metabolic profile persisted with chronic use
Three key findings result from our study: (1) pwIIH treated with GLP-1-RAs lose significantly more weight than pwIIH electing for UCWM only, (2) treatment with GLP-1-RAs is associated with favorable headache outcomes, and (3) treatment with GLP-1-RAs is not associated with any severe adverse events in IIH, and thus presents a safe treatment option for weight management in pwIIH
Check out the most affordable weight-loss clinics